XORTX Therapeutics Inc. (XRTX.V)

CAD 1.62

(-7.43%)

Inventory Summary of XORTX Therapeutics Inc.

  • XORTX Therapeutics Inc.'s latest annual inventory in 2023 was - CAD , up 100.0% from previous year.
  • XORTX Therapeutics Inc.'s latest quarterly inventory in 2024 Q2 was 207.29 Thousand USD , up 100.0% from previous quarter.
  • XORTX Therapeutics Inc. reported annual inventory of -135.32 Thousand CAD in 2022, up 50.62% from previous year.
  • XORTX Therapeutics Inc. reported annual inventory of -274.05 Thousand CAD in 2021, down 0.0% from previous year.
  • XORTX Therapeutics Inc. reported quarterly inventory of 207.29 Thousand USD for 2024 Q2, up 100.0% from previous quarter.
  • XORTX Therapeutics Inc. reported quarterly inventory of 247.94 Thousand USD for 2023 Q4, up 892.1% from previous quarter.

Annual Inventory Chart of XORTX Therapeutics Inc. (2023 - 2014)

Historical Annual Inventory of XORTX Therapeutics Inc. (2023 - 2014)

Year Inventory Inventory Growth
2023 - CAD 100.0%
2022 -135.32 Thousand CAD 50.62%
2021 -274.05 Thousand CAD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%
2017 - CAD 0.0%
2016 - CAD 0.0%
2014 - CAD 0.0%

Peer Inventory Comparison of XORTX Therapeutics Inc.

Name Inventory Inventory Difference
Arch Biopartners Inc. - CAD NaN%
Covalon Technologies Ltd. 5.94 Million CAD 100.0%
Hemostemix Inc. - CAD NaN%
Universal Ibogaine Inc. - CAD NaN%
Kane Biotech Inc. 250.41 Thousand CAD 100.0%
MedMira Inc. 182.42 Thousand CAD 100.0%
Marvel Biosciences Corp. - CAD NaN%
NervGen Pharma Corp. - CAD NaN%